VRCA (STOCKS)
Verrica Pharmaceuticals Inc. Common Stock
$5.690000
-0.340000 (-5.64%)
Prev close: $6.030000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jayson M. Rieger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $90.92M
- Employees
- 71
- P/E (TTM)
- -1.65
- P/B (TTM)
- -3.17
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $30.83M |
| Benefits Costs and Expenses | $84.15M |
| Costs And Expenses | $57.89M |
| Nonoperating Income/Loss | -$9.61M |
| Operating Expenses | $47.23M |
| Selling, General, and Administrative Expenses | $36.98M |
| Research and Development | $7.50M |
| Other Operating Expenses | $2.75M |
| Operating Income/Loss | -$16.40M |
| Income/Loss From Continuing Operations After Tax | -$26.01M |
| Income/Loss From Continuing Operations Before Tax | -$53.32M |
| Net Income/Loss | -$26.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$26.01M |
| Net Income/Loss Available To Common Stockholders, Basic | -$26.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $11.37 |
| Diluted Earnings Per Share | $11.37 |
| Basic Average Shares | 160,963,921 |
| Diluted Average Shares | 160,966,466 |
| Assets | $40.90M |
| Current Assets | $36.28M |
| Inventory | $2.30M |
| Other Current Assets | $33.97M |
| Noncurrent Assets | $4.62M |
| Fixed Assets | $225.00K |
| Other Non-current Assets | $4.40M |
| Liabilities | $57.94M |
| Current Liabilities | $28.91M |
| Accounts Payable | $1.59M |
| Wages | $1.79M |
| Other Current Liabilities | $25.53M |
| Noncurrent Liabilities | $29.03M |
| Long-term Debt | $21.62M |
| Other Non-current Liabilities | $7.41M |
| Equity | -$17.04M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$17.04M |
| Liabilities And Equity | $40.90M |
| Net Cash Flow From Operating Activities | -$29.10M |
| Net Cash Flow From Operating Activities, Continuing | -$29.10M |
| Net Cash Flow From Investing Activities | $25.24M |
| Net Cash Flow From Investing Activities, Continuing | $25.24M |
| Net Cash Flow From Financing Activities | $27.23M |
| Net Cash Flow From Financing Activities, Continuing | $27.23M |
| Net Cash Flow | $23.37M |
| Net Cash Flow, Continuing | $23.37M |
| Comprehensive Income/Loss | -$26.01M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$26.01M |
| Other Comprehensive Income/Loss | $0.00 |